• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Henry Daniel R bought $50,000 worth of shares (10,084 units at $4.96), increasing direct ownership by 8% to 129,884 units (SEC Form 4)

    6/16/25 9:00:04 PM ET
    $PAYS
    Real Estate
    Real Estate
    Get the next $PAYS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    HENRY DANIEL R

    (Last) (First) (Middle)
    2615 ST. ROSE PARKWAY

    (Street)
    HENDERSON NV 89052

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Paysign, Inc. [ PAYS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/16/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/16/2025 P 10,084.198 A $4.9583(1) 129,884.198 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.9385 to $4.99, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares pourcased at each separate price within the range set forth in this footnote.
    /s/ Daniel R. Henry 06/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PAYS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PAYS

    DatePrice TargetRatingAnalyst
    12/20/2024$6.00Buy
    Lake Street
    3/30/2022$4.00Mkt Perform
    Barrington Research
    3/24/2022Buy → Neutral
    Ladenburg Thalmann
    8/20/2021$3.50Neutral → Buy
    DA Davidson
    8/19/2021Neutral → Buy
    DA Davidson
    8/12/2021$3.50 → $3.75Neutral → Buy
    Ladenburg Thalmann
    More analyst ratings

    $PAYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board

    Company Positioned for Growth Serving Life Sciences Industries Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced that its board of directors has elected Dan Henry as Chairman of the Board, succeeding Mark Newcomer who will continue in his role as President and Chief Executive Officer. "Dan brings decades of experience in fintech, payments and leadership strategy along with a deep understanding of Paysign's business and long‑term goals," said Mark Newcomer, President and CEO of Paysign. "His vision and insi

    8/14/25 8:30:00 AM ET
    $EEFT
    $GDOT
    $PAYS
    Investment Bankers/Brokers/Service
    Finance
    Finance: Consumer Services
    Real Estate

    Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive pharma patient affordability offerings, financial technology products and integrated payment processing, today announced they will be presenting at the Oppenheimer 28th Annual Technology, Internet & Communications Conference to be held August 11-13, 2025, through a virtual format. The conference focuses on providing an expansive look across the dynamic sector of the world economy at existing and emerging technologies and providing potential investors the opportunity to evaluate public companies at the forefront of these technological innovations. Paysign's Chief Financial Officer, Jeff Baker, is sch

    8/8/25 10:00:00 AM ET
    $PAYS
    Real Estate

    Paysign, Inc. Reports Second Quarter 2025 Financial Results

    Second quarter 2025 total revenues of $19.08 million, up 33.1% from second quarter 2024 Second quarter 2025 net income of $1.39 million, up 99.1% from $697 thousand a year ago, while diluted earnings per share was $0.02, versus $0.01 for second quarter 2024 Second quarter 2025 Adjusted EBITDA of $4.51 million, up 101.8% from $2.24 million a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.04 for second quarter 20241 Added 123 net plasma centers during second quarter 2025, all which went live June 16. We exited the quarter with 607 centers; average monthly revenue per plasma center decreased to $7,098 compared to $7,916 for the same period last year; year-over-

    8/5/25 4:05:00 PM ET
    $PAYS
    Real Estate

    $PAYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on PaySign with a new price target

    Lake Street initiated coverage of PaySign with a rating of Buy and set a new price target of $6.00

    12/20/24 8:45:02 AM ET
    $PAYS
    Real Estate

    Barrington Research initiated coverage on PaySign with a new price target

    Barrington Research initiated coverage of PaySign with a rating of Mkt Perform and set a new price target of $4.00

    3/30/22 8:15:53 AM ET
    $PAYS
    Real Estate

    PaySign downgraded by Ladenburg Thalmann

    Ladenburg Thalmann downgraded PaySign from Buy to Neutral

    3/24/22 7:30:30 AM ET
    $PAYS
    Real Estate

    $PAYS
    SEC Filings

    View All

    SEC Form 10-Q filed by Paysign Inc.

    10-Q - Paysign, Inc. (0001496443) (Filer)

    8/6/25 8:04:06 AM ET
    $PAYS
    Real Estate

    Paysign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    8/5/25 4:06:19 PM ET
    $PAYS
    Real Estate

    Paysign Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    6/5/25 9:00:50 PM ET
    $PAYS
    Real Estate

    $PAYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Henry Daniel R bought $50,000 worth of shares (10,084 units at $4.96), increasing direct ownership by 8% to 129,884 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    6/16/25 9:00:04 PM ET
    $PAYS
    Real Estate

    Director Henry Daniel R bought $67,716 worth of shares (19,800 units at $3.42), increasing direct ownership by 25% to 99,800 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/28/25 8:07:31 PM ET
    $PAYS
    Real Estate

    Mina Bruce A bought $5,801 worth of shares (1,206 units at $4.81), increasing direct ownership by 0.56% to 218,500 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/15/24 6:19:59 PM ET
    $PAYS
    Real Estate

    $PAYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Newcomer Mark sold $440,396 worth of shares (62,158 units at $7.09) and converted options into 150,000 shares, increasing direct ownership by 1% to 8,750,728 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    8/4/25 9:17:59 PM ET
    $PAYS
    Real Estate

    Chief Legal Officer Strobo Robert converted options into 64,000 shares and sold $187,904 worth of shares (26,521 units at $7.09), increasing direct ownership by 18% to 247,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    8/4/25 9:17:32 PM ET
    $PAYS
    Real Estate

    EVP, Operations Herman Joan M converted options into 36,000 shares and sold $100,325 worth of shares (14,160 units at $7.09), increasing direct ownership by 3% to 821,583 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    8/4/25 9:17:07 PM ET
    $PAYS
    Real Estate

    $PAYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Paysign Inc.

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    11/14/24 7:00:30 AM ET
    $PAYS
    Real Estate

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    2/12/24 12:36:58 PM ET
    $PAYS
    Real Estate

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    1/24/24 4:05:27 PM ET
    $PAYS
    Real Estate

    $PAYS
    Leadership Updates

    Live Leadership Updates

    View All

    Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

    Paysign Strengthens Leadership in Technology for Plasma and Pharmaceutical Industries  Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the assets of Gamma Innovation LLC (Gamma), significantly enhancing Paysign's capabilities in plasma donor and pharmaceutical patient engagement technologies. As part of this strategic acquisition, Paysign has appointed Michael Ngo, former Managing Member of Gamma, as its Chief Innovation Officer. "This acquisition represents an exciting milestone for Paysign as we accelerate our growth strategy and expand our

    3/25/25 8:05:00 AM ET
    $PAYS
    Real Estate

    $PAYS
    Financials

    Live finance-specific insights

    View All

    Paysign, Inc. Reports Second Quarter 2025 Financial Results

    Second quarter 2025 total revenues of $19.08 million, up 33.1% from second quarter 2024 Second quarter 2025 net income of $1.39 million, up 99.1% from $697 thousand a year ago, while diluted earnings per share was $0.02, versus $0.01 for second quarter 2024 Second quarter 2025 Adjusted EBITDA of $4.51 million, up 101.8% from $2.24 million a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.04 for second quarter 20241 Added 123 net plasma centers during second quarter 2025, all which went live June 16. We exited the quarter with 607 centers; average monthly revenue per plasma center decreased to $7,098 compared to $7,916 for the same period last year; year-over-

    8/5/25 4:05:00 PM ET
    $PAYS
    Real Estate

    Paysign, Inc. Reports First Quarter 2025 Financial Results

    First quarter 2025 total revenues of $18.60 million, up 41.0% from first quarter 2024 First quarter 2025 net income of $2.59 million, or diluted earnings per share of $0.05, versus net income of $309 thousand, or diluted earnings per share of $0.01, for first quarter 2024 First quarter 2025 Adjusted EBITDA of $4.96 million, up 193.3% from $1.69 million a year ago, while diluted Adjusted EBITDA per share was $0.09 versus $0.03 for first quarter 20241 Total plasma center count increased by four net centers during first quarter 2025, exiting the quarter with 484 centers; revenue per plasma center decreased to $6,517 compared to $7,414 for the same period last year; year-over-year plasma

    5/8/25 4:05:00 PM ET
    $PAYS
    Real Estate

    Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results

    For the Full-Year Full-year 2024 total revenues of $58.38 million, up 23.5% from full-year 2023 Full-year 2024 net income of $3.82 million, or diluted earnings per share of $0.07, versus net income of $6.46 million, or diluted earnings per share of $0.12 for full-year 2023 Full-year 2024 Adjusted EBITDA of $9.62 million, up 43.3% from $6.71 million a year ago, while diluted Adjusted EBITDA per share was $0.17 versus $0.12 for full-year 20231 Total plasma center count increased by 16 during 2024, exiting the year with 480 centers, contributing to a 4.6% increase in plasma revenue versus the same period last year Added 33 net patient affordability programs during 2024, exiting the y

    3/25/25 4:03:00 PM ET
    $PAYS
    Real Estate